Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors

Considering the risk of reactivation of latent tuberculosis infection (LTBI), not only before starting tumor necrosis factor inhibitors but also before non-TNF inhibitor therapy, LTBI screening is routinely recommended for patients with inflammatory bowel disease (IBD). However, data on the positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyuwon, Jo, Kyung-Wook, Shim, Tae Sun, Park, Jin Hwa, Hwang, Sung Wook, Park, Sang Hyoung, Yang, Dong-Hoon, Byeon, Jeong-Sik, Myung, Seung-Jae, Yang, Suk-Kyun, Ye, Byong Duk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175966/
https://www.ncbi.nlm.nih.gov/pubmed/34095175
http://dx.doi.org/10.3389/fmed.2021.670242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175966/
https://www.ncbi.nlm.nih.gov/pubmed/34095175
http://dx.doi.org/10.3389/fmed.2021.670242

Ejemplares similares